Baby Steps: Congress Likely Won't Move Quickly on Drug Prices

iStock

Baby Steps: Congress Likely Won't Move Quickly on Drug Prices

Oct, 10th 2016

(iStock)

Federal lawmakers will continue to rail against the high cost of prescription drugs in the next few years, but their most likely actions will be limited to relatively small steps such as the enactment of measures intended to approve more generics.

“There is not going to be a magic bullet," said Douglas Holtz-Eakin, a former director of the Congressional Budget Office who now leads the conservative American Action Forum. “There are a bunch of little levers they can pull.”

Net spending on prescription medicines in the United States rose by 8.5 percent last year to $309.5 billion from the previous year and could hit as much as $400 billion by 2020, according to consulting firm IMS Health.

One of the most promising bills addressing drug...

Read More

Join Us. We are waiting for you!

Sign Up Today!

We welcome you to our community where you can gather and share information on debts and issues which may have your life unsettled. Together we thrive!


Logo mobile 4b2fda9e088d7249be95ede0cc3adea2de299a346ba55b450264e0c976b239c5

Join our community Today! IT'S FREE

Our Interactive Knowledge Base Has All The Infomation You Need To Settle Your Debt & Settle Your Life™

SIGN UP NOW!

Join, Resolve & Share!